NIOX Group Plc (AIM:NIOX)
London · Delayed Price · Currency is GBP · Price in GBX 67.00
+0.80 (1.21%)
Jan 22, 2026, 5:08 PM GMT
NIOX Group Market Cap
NIOX Group has a market cap or net worth of 276.65 million as of January 22, 2026. Its market cap has increased by 19.03% in one year.
Market Cap
276.65M
Enterprise Value
266.05M
Revenue
46.00M
Ranking
n/a
PE Ratio
58.39
Stock Price
67.00
Market Cap Chart
Since March 13, 2014, NIOX Group's market cap has decreased from 581.01M to 276.65M, a decrease of -52.38%. That is a compound annual growth rate of -6.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 279.99M | 0.90% |
| Dec 31, 2025 | 277.48M | 10.67% |
| Dec 31, 2024 | 250.73M | -11.04% |
| Dec 29, 2023 | 281.86M | 84.10% |
| Dec 30, 2022 | 153.10M | -9.72% |
| Dec 31, 2021 | 169.58M | 51.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 206.86B |
| GSK plc | 71.72B |
| Haleon | 33.21B |
| Smith & Nephew | 10.20B |
| PureTech Health | 323.37M |
| Integrated Diagnostics Holdings | 275.86M |
| Avacta Group | 242.76M |
| Faron Pharmaceuticals Oy | 198.16M |